Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study

✍ Scribed by John C. Stevenson; Gemma Durand; Elke Kahler; Tomasz Pertyński

• Book ID: 116732190
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 383 KB
• Volume: 67
• Category: Article
• ISSN: 0378-5122
• DOI: 10.1016/j.maturitas.2010.07.002